Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DX
2026
Dynex Capital
DX
$3.15B
| $1.58M | ﹤0.01% |
132,000
+96,100
| +268% | +$1.15M |
|
2027
Solid Biosciences
SLDB
$794M
| $1.57M | ﹤0.01% |
277,564
+208,793
| +304% | +$1.87M |
|
|
CNTA
2028
DELISTED
Centessa Pharmaceuticals
CNTA
| $1.57M | ﹤0.01% |
173,700
-45,100
| -21% | -$428K |
|
2029
Cimpress
CMPR
$2.39B
| $1.57M | ﹤0.01% |
17,900
-12,700
| -42% | -$1.11M |
|
2030
iShares International Select Dividend ETF
IDV
$8.45B
| $1.57M | ﹤0.01% |
56,600
-70,500
| -55% | -$2M |
|
2031
Minerals Technologies
MTX
$2.36B
| $1.56M | ﹤0.01% |
+18,800
| New | +$1.49M |
|
2032
The RealReal
REAL
$1.46B
| $1.56M | ﹤0.01% |
+489,900
| New | +$1.81M |
|
2033
Northrim BanCorp
NRIM
$590M
| $1.56M | ﹤0.01% |
108,400
+23,200
| +27% | +$299K |
|
2034
Liberty Broadband Class A
LBRDA
$4.89B
| $1.56M | ﹤0.01% |
28,600
-1,200
| -4% | -$62.1K |
|
2035
Babcock & Wilcox
BW
$1.39B
| $1.56M | ﹤0.01% |
1,075,138
+82,100
| +8% | +$98.7K |
|
2036
Xtrackers S&P 500 ESG ETF
SNPE
$2.63B
| $1.56M | ﹤0.01% |
31,100
+4,900
| +19% | +$235K |
|
|
SPYU
2037
MAX S&P 500 4x Leveraged ETN
SPYU
$258M
| $1.55M | ﹤0.01% |
+73,800
| New | +$1.38M |
|
|
TBI
2038
Trueblue
TBI
$215M
| $1.55M | ﹤0.01% |
150,600
-95,800
| -39% | -$1.04M |
|
2039
Electromed
ELMD
$337M
| $1.55M | ﹤0.01% |
103,004
+4,736
| +5% | +$74K |
|
2040
Twin Disc
TWIN
$329M
| $1.55M | ﹤0.01% |
131,193
+32,673
| +33% | +$484K |
|
2041
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
| $1.54M | ﹤0.01% |
37,200
+21,400
| +135% | +$892K |
|
|
PPIH
2042
Perma-Pipe International
PPIH
$196M
| $1.54M | ﹤0.01% |
173,412
+3,119
| +2% | +$26.6K |
|
2043
Blend Labs
BLND
$431M
| $1.54M | ﹤0.01% |
653,660
-90,000
| -12% | -$239K |
|
2044
Amylyx Pharmaceuticals
AMLX
$2.26B
| $1.54M | ﹤0.01% |
811,488
+106,888
| +15% | +$207K |
|
2045
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.75B
| $1.54M | ﹤0.01% |
12,500
-2,900
| -19% | -$351K |
|
2046
Zedge
ZDGE
$38.6M
| $1.54M | ﹤0.01% |
505,014
+14,404
| +3% | +$38.8K |
|
2047
Acushnet Holdings
GOLF
$5.93B
| $1.54M | ﹤0.01% |
24,200
+18,300
| +310% | +$1.17M |
|
|
NTST
2048
NETSTREIT Corp
NTST
$2.09B
| $1.54M | ﹤0.01% |
95,400
-163,200
| -63% | -$2.81M |
|
2049
Ligand Pharmaceuticals
LGND
$5.76B
| $1.53M | ﹤0.01% |
18,200
-28,900
| -61% | -$2.3M |
|
2050
Nucor
NUE
$58.6B
| $1.53M | ﹤0.01% |
9,700
+400
| +4% | +$69.5K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.